Orchestra BioMed Holdings Inc

NAS:OBIO (USA)  
$ 6.04 +0.35 (+6.15%) 10:08 PM EST
At Loss
P/B:
2.71
Market Cap:
$ 215.89M
Enterprise V:
$ 118.51M
Volume:
33.35K
Avg Vol (2M):
58.10K
Volume:
33.35K
At Loss
Avg Vol (2M):
58.10K

Business Description

Orchestra BioMed Holdings Inc
NAICS : 541714 SIC : 2833
ISIN : US68572M1062
Description
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. Orchestra BioMed's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Name Current Vs Industry Vs History
Cash-To-Debt 9.5
Equity-to-Asset 0.69
Debt-to-Equity 0.14
Debt-to-EBITDA -0.3
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.31
Distress
Grey
Safe
Beneish M-Score -1.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 41.29
9-Day RSI 38.71
14-Day RSI 39.79
6-1 Month Momentum % 35.59
12-1 Month Momentum % -8.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.13
Quick Ratio 5.13
Cash Ratio 5.07
Days Inventory 478.79
Days Sales Outstanding 16.22
Days Payable 7812.93

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -1.25

Financials (Next Earnings Date:2024-02-29 Est.)

OBIO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:OBIO

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Orchestra BioMed Holdings Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 2.498
EPS (TTM) ($) -1.13
Beta 0
Volatility % 156.51
14-Day RSI 39.79
14-Day ATR ($) 0.568956
20-Day SMA ($) 6.765
12-1 Month Momentum % -8.64
52-Week Range ($) 4.2552 - 23.39
Shares Outstanding (Mil) 35.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Orchestra BioMed Holdings Inc Filings

Filing Date Document Date Form
No Filing Data

Orchestra BioMed Holdings Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Orchestra BioMed Holdings Inc Frequently Asked Questions

What is Orchestra BioMed Holdings Inc(OBIO)'s stock price today?
The current price of OBIO is $6.04. The 52 week high of OBIO is $23.39 and 52 week low is $4.26.
When is next earnings date of Orchestra BioMed Holdings Inc(OBIO)?
The next earnings date of Orchestra BioMed Holdings Inc(OBIO) is 2024-02-29 Est..
Does Orchestra BioMed Holdings Inc(OBIO) pay dividends? If so, how much?
Orchestra BioMed Holdings Inc(OBIO) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1